Evidence map›Paper›PMID 31779207›Full record

ReviewMaterials (Basel, Switzerland)2019

From 2-D to 0-D Boron Nitride Materials, The Next Challenge.

Luigi Stagi, Junkai Ren, Plinio Innocenzi

Abstract readReview
In one paragraph

Review in Materials (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Boron Nitride-Titania Mesoporous Film Heterostructures.Langmuir : the ACS journal of surfaces and colloids · 2021
    Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Luigi StagiLaboratorio di Scienza dei Materiali e Nanotecnologie, CR-INSTM, Dipartimento di Chimica e Farmacia, Università di Sassari, Via Vienna 2, 07100 Sassari, Italy.ORCID 0000-0002-7238-8425
Junkai RenLaboratorio di Scienza dei Materiali e Nanotecnologie, CR-INSTM, Dipartimento di Chimica e Farmacia, Università di Sassari, Via Vienna 2, 07100 Sassari, Italy.ORCID 0000-0002-5099-8345
Plinio InnocenziLaboratorio di Scienza dei Materiali e Nanotecnologie, CR-INSTM, Dipartimento di Chimica e Farmacia, Università di Sassari, Via Vienna 2, 07100 Sassari, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The discovery of graphene has paved the way for intense research into 2D materials which is expected to have a tremendous impact on our knowledge of material properties in small dimensions. Among other materials, boron nitride (BN) nanomaterials have shown remarkable features with the possibility of being used in a large variety of devices. Photonics, aerospace, and medicine are just some of the possible fields where BN has been successfully employed. Poor scalability represents, however, a primary limit of boron nitride. Techniques to limit the number of defects, obtaining large area sheets and the production of significant amounts of homogenous 2D materials are still at an early stage. In most cases, the synthesis process governs defect formation. It is of utmost importance, therefore, to achieve a deep understanding of the mechanism behind the creation of these defects. We reviewed some of the most recent studies on 2D and 0D boron nitride materials. Starting with the theoretical works which describe the correlations between structure and defects, we critically described the main BN synthesis routes and the properties of the final materials. The main results are summarized to present a general outlook on the current state of the art in this field.

Indexed as

2D materialsboron nitridefluorescencenanocompositesquantum dots

Identifiers

PMID31779207
PMCPMC6926581

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.